THX PHARMA SACA (ALTHX.PA) Forecast, Price Target & Analyst Ratings
EPA:ALTHX • FR0013286259
3.25 EUR
+0.05 (+1.56%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for THX PHARMA SACA (ALTHX.PA).
Forecast Snapshot
Consensus Price Target
€4.49
+ 38.09% Upside
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
86.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€4.49
Upside
+ 38.09%
From current price of €3.25 to mean target of €4.49, Based on 9 analyst forecasts
Low
€4.44
Median
€4.49
High
€4.62
Price Target Revisions
1 Month
0.00%
3 Months
-0.52%
Price Target Summary
9 analysts have analysed ALTHX.PA and the average price target is 4.49 EUR. This implies a price increase of 38.09% is expected in the next year compared to the current price of 3.25.
The average price target has been revised downward by 0.52% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
86.67%
ALTHX.PA was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ALTHX.PA.
In the previous month the buy percentage consensus was at a similar level.
ALTHX.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 566.5K | N/A -100.00% | 51.5K | 137.33K | 15.45M | N/A | |||||||
| EBITDA YoY % growth | N/A | N/A | -4.324M -32.28% | -6.798M -157.50% | -6.077M -4.14% | -4.12M 20.77% | 5.511M -45.88% | -6.18M 29.03% | 5.511M -24.67% | -6.541M 65.70% | -7.21M -184.55% | N/A | |
| EBIT YoY % growth | -1.116M | N/A -84.39% | -5.047M -32.10% | -9.133M -157.08% | -9.03M -5.53% | -3.914M 17.32% | 5.614M -55.96% | -7.21M 34.22% | -7.21M -22.15% | -7.21M 65.59% | -7.21M -174.14% | N/A | |
| Operating Margin | -197.07% | N/A | -9,800.00% | -6,650.17% | N/A | N/A | 36.34% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.26 | -2.03 -61.42% | -1.73 14.90% | 5.48 417.00% | 2.47 -54.97% | -1.83 -174.08% | -0.99 45.78% | -0.12 88.00% | -0.10 13.33% | 0.10 200.00% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
THX PHARMA SACA / ALTHX.PA Forecast FAQ
What is the price target for ALTHX stock?
9 analysts have analysed ALTHX.PA and the average price target is 4.49 EUR. This implies a price increase of 38.09% is expected in the next year compared to the current price of 3.25.
What is the consensus rating for THX PHARMA SACA (ALTHX.PA) stock?
The consensus rating for THX PHARMA SACA (ALTHX.PA) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.